Arlington-backed AVS Bio acquires UK bioreagent supplier Biorbyt in add-on deal
Wednesday, September 23, 2026 · first reported by PE Hub
Arlington Capital Partners-backed AVS Bio acquires Cambridge-based bioreagent supplier Biorbyt (founded 2011, 1M+ SKU catalog) as add-on consolidation.
- Asset class
- Private equity
- Geography
- North America, Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- KKR, Blackstone among PE firms eyeing windscreen repair group CaryPrivate Equity Wire
- One Rock Capital Partners completes $470m sale of EnviroServe to Clean HarborsPE Hub
- DWS to acquire Peakside in European property pushAlternative Credit Investor +3
- Fvlcrum Funds strikes deal for defense simulation specialist Fidelity Technology ServicesPE Hub
- Summit Investments to buy into Ohio GatheringInfrastructure Investor
- Mutares receives offer to sell controlling stake in Lapeyre to Italian investorsPE Hub +1